# Gland Pharma Limited, Units I+II Pashamylaram Site, Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca

> Inspection records and compliance data for Gland Pharma Limited, Units I+II Pashamylaram Site in Hyderabad. 7 FDA inspections on record, 4 Form 483s, last inspected August 02, 2024.

---

## Details

- Name: Gland Pharma Limited, Units I+II Pashamylaram Site
- FEI Number: 3009864167
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 54 55 64 - 68 Plots 42 - 52, Sy No 166; 171 172 - 177 Sangareddy Dist
- City: Hyderabad
- Country Name: India
- Address: 54 55 64 - 68 Plots 42 - 52, Sy No 166; 171 172 - 177 Sangareddy Dist, Hyderabad, India
- Country: India

## Related Documents

- [483 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2024-08-02](https://www.keypedia.com/records/483/gland-pharma-limited-units-iii-pashamylaram-site/ec9c17b8-eaa1-4d9f-aa4a-0631bfca1f54) — source: FDA, date: August 2, 2024
- [FDA Inspection 1244660 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2024-08-02](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/9a9126ce-3d6e-4ad7-891a-5cdd10d186bd) — source: FDA, date: August 2, 2024
- [483 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2023-08-26](https://www.keypedia.com/records/483/gland-pharma-limited-units-iii-pashamylaram-site/c2f4d2bb-1f08-4cc0-b659-19378e201a83) — source: FDA, date: August 26, 2023
- [FDA Inspection 1216053 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2023-08-26](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/955ba795-ebdd-4ebb-861f-16909163e529) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2023
- [FDA Inspection 1210478 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2023-06-27](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/cdefda8a-9fac-4c48-90f1-47b5c117ec07) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2023
- [483 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2019-11-07](https://www.keypedia.com/records/483/gland-pharma-limited-units-iii-pashamylaram-site/767d64c6-92ff-4f24-8fde-19bd74da6cdc) — source: FDA, date: November 7, 2019
- [FDA Inspection 1109239 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2019-11-07](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/b1e79e8a-4766-4a82-8ce3-2f50924d5757) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2019
- FDA Inspection 1057719 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2018-05-29 — source: FDA, date: May 29, 2018
- [FDA Inspection 1043371 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2018-02-23](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/2a89c877-04b5-44c9-bda9-2d69a6bcbb57) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2018
- FDA Inspection 944183 - Gland Pharma Limited, Units I+II Pashamylaram Site - 2015-09-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2015

## Related Companies

- [Celltrion Pharm, Inc.](https://www.keypedia.com/companies/celltrion-pharm-inc/481a4273-bf7e-4b37-8cd8-08b977ba576b)
- [Bausch & Lomb Incorporated](https://www.keypedia.com/companies/bausch-lomb-incorporated/be8adcb1-2ff8-4ee1-b354-75428f7b75a6)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [DPT Laboratories Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/b2d45aa5-6cf4-4401-87a2-35470321dc30)
- [Rechon Life Science AB](https://www.keypedia.com/companies/rechon-life-science-ab/ce84eed4-ada6-40a0-9005-2c2d6bbd729d)
- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [Ferndale Laboratories, Inc.](https://www.keypedia.com/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)
- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [Consumer Safety Officer](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)